Related by context. Frequent words. (Click for all words.) 59 eculizumab 56 picoplatin 56 Phase 2b 55 pralatrexate 54 Zerenex 54 tivozanib 54 ofatumumab 54 FOLOTYN 53 HspE7 53 MGCD# [001] 53 VELCADE 53 blinatumomab 53 ADVEXIN 53 orBec R 53 perifosine 52 Phase 2b study 52 PROVENGE 52 carfilzomib 52 Phase 2b trial 52 ISIS # 52 Perifosine 51 Xcytrin 51 Phase Ib 51 phase IIb 51 MGCD# [002] 51 Azixa 51 Defibrotide 51 ViRexx 51 vandetanib 51 Satraplatin 50 Phase 2a trial 50 Phase IIa clinical 50 Opexa 50 APF# 50 Marqibo 50 Stimuvax 50 NGX# 50 Alpharadin 50 INCB# [002] 50 L MTP PE 50 Locteron 50 brentuximab vedotin 50 panitumumab 50 tamibarotene 50 satraplatin 50 Phase IIb clinical 50 voreloxin 50 RG# [001] 50 TREANDA 49 LymphoStat B 49 TNFerade 49 BiovaxID 49 oncology indications 49 ZYBRESTAT 49 ERBITUX 49 AP# [003] 49 DAVANAT R 49 orBec ® 49 GATTEX 49 elesclomol 49 AS# [003] 49 Genasense 49 Phase 1b 49 CYT# 49 XL# [003] 49 Phase 2a clinical 48 DAVANAT ® 48 GVAX immunotherapy 48 Phase 2a 48 Phase III 48 Vidaza 48 cutaneous T cell 48 Phase 2b clinical 48 clofarabine 48 docetaxel 48 ABRAXANE 48 Tovaxin 48 DSMB 48 HRPC 48 confirmatory Phase 3 48 chemotherapeutics 48 ASA# 48 CBLB# 48 Phase III clinical 48 ANA# 48 REVLIMID 48 Cotara 48 Homspera 47 Multikine 47 TroVax 47 tesetaxel 47 REOLYSIN R 47 conformance testing 47 ThermoDox 47 sunitinib 47 SCTE 47 pivotal Phase III 47 randomized Phase 47 gefitinib 47 anticancer agents 46 ipilimumab